| Literature DB >> 34055995 |
Yu Liu1,2, Dan-Qian Chen1, Jing-Xue Han1,2, Ting-Ting Zhao1, Shu-Ju Li2.
Abstract
Renal interstitial fibrosis (RIF) is the main pathological manifestation of end-stage renal disease. Recent studies have shown that endoplasmic reticulum (ER) stress is involved in the pathogenesis and development of RIF. Traditional Chinese medicine (TCM), as an effective treatment for kidney diseases, can improve kidney damage by affecting the apoptotic signaling pathway mediated by ER stress. This article reviews the apoptotic pathways mediated by ER stress, including the three major signaling pathways of unfolded protein response, the main functions of the transcription factor C/EBP homologous protein. We also present current research on TCM treatment of RIF, focusing on medicines that regulate ER stress. A new understanding of using TCM to treat kidney disease by regulating ER stress will promote clinical application of Chinese medicine and discovery of new drugs for the treatment of RIF.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34055995 PMCID: PMC8147530 DOI: 10.1155/2021/6667791
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.246
Figure 1Mechanisms of ER stress-mediated apoptosis. Once PERK is activated, eIF2α is phosphorylated to achieve ATF4 translation and CHOP activation. Activation of the IRE1α domain processes uncut XBP1mRNA to produce activated XBP1(s), which enters the nucleus and controls the expression of CHOP. ATF6α is transported to the Golgi apparatus, where it is processed by the proteases SP1 and SP2 to produce cytoplasmic fragment ATF6, which regulates CHOP activation in the nucleus. CHOP can trigger the endogenous apoptosis pathway and promote cell apoptosis by inhibiting the upregulation of BCL-2. CHOP can also upregulate the expression of TRB3, preventing Akt phosphorylation. CHOP can also initiate the exogenous apoptosis pathway through DR4 and DR5 and can additionally trigger the ERO1α-IP3R-Ca2+-CaMKII pathway.
Traditional Chinese medicines effective for renal interstitial fibrosis.
| Name | Animal model | Targeted pathway | Targeted protein | Reference | |
|---|---|---|---|---|---|
| Compounds | Resveratrol | UUO rats | eIF2 | [ | |
| STZ-induced rats | PERK | GRP78, p-PERK, ATF4, CHOP | [ | ||
| Stachydrine | UUO rats | PERK, CHOP, caspase-3 | [ | ||
| UUO rats | Caspase-12, caspase-9 | [ | |||
| Ginsenoside-Rg1 | UUO rats | GRP78, CHOP, caspase-12 | [ | ||
| CsA-induced rats | GRP78, CHOP | [ | |||
| Astragaloside IV | STZ-induced rats; HG-induced podocytes | PERK-ATF4-CHOP | GRP78, CHOP, ATF4, TRB3 | [ | |
| STZ-induced rats; TM-induced podocytes | eIF2 | [ | |||
| STZ+HFD-induced rats | GRP78, p-PERK, PERK, ATF4, CHOP, cleaved caspase-3, Bax/Bcl-2 ratio | [ | |||
| Curcumin | STZ+HFD-induced mice | ER stress-induced apoptosis; MAPK | GRP78, p-JNK, p-PERK1/2, CYP2E1, cleaved caspase-12, cleaved caspase-3, CHOP | [ | |
| Emodin | KKAy mice, HG or TM-induced podocytes | PERK | GRP78, p-PERK, p-eIF2 | [ | |
| Morin hydrate | CP-induced HEK-293 cells, CP-induced ICR mice | PERK, IRE-1 | [ | ||
| Withaferin A | UUO mouse | GRP78, GRP94, ATF4, CHOP, p-eIF2 | [ | ||
|
| |||||
| Extracts |
| LPS-induced PK1 cells and MDCK cells, LPS-induced rats | GRP78, caspase-12, Beclin-1, caspase-3, PARP, Bax/Bcl-2 | [ | |
| Gingko biloba | STZ+HFD-induced mice | GRP78, ATF6 | [ | ||
|
| STZ-induced rats | NRF2 signaling | GRP78, PERK, IRE-1, p-eIF2 | [ | |
|
| |||||
| Chinese herbal formula | Chaiqin Chengqi Decoction | Taurocholate-induced rats; TNF- | Caspase-9, cleaved caspase-3, GRP78/BIP, IRE1 | [ | |
| Shenshuaiyin Decoction | Adenine-induced rats | ATF6/CHOP | ATF6, CHOP, caspase-3 | [ | |
| Tongluo Baoshen Formula | STZ-induced rats | JNK | GRP78, p-JNK | [ | |
| Danggui Buxue Decoction | STZ-induced rats | IRE1 | p-IRE1 | [ | |
| Manshen Kangning Formula | Adenine-induced rats | PERK-eIF2 | GRP78, CHOP, ATF4 | [ | |
| Huaiqihuang | MPC5 podocyte | p-ERK/CHOP pathway | p-PERK, PERK, CHOP | [ | |
Abbreviations: ATF4: activated transcription factor 4; ATF6: activated transcription factor 6; BCL2: B-cell lymphoma 2; CHOP: transcription factor C/EBP homologous protein; CP: cisplatin; CsA: cyclosporine A; CYP2E1: cytochrome P450 protein; eIF2α: eukaryotic translation initiation factor 2α; ER: endoplasmic reticulum; GRP78: glucose regulatory protein 78; HEK-293: human embryonic kidney epithelial cell; HFD: high-fat diet; HG: high glucose; HK-2: human renal proximal tubular cell; IRE1α: inositol requirement protein 1α; JNK: c-Jun N-terminal kinase; LPS: lipopolysaccharide; MAPK: mitogen-activated protein kinase; MDCK: Madin-Darby canine kidney epithelial cell; ORP150: oxygen regulator 150; p-eIF2α: phosphorylation-eIF2α; p-IRE1α: phosphorylation-IRE1α; p-JNK: phosphorylation-JNK; PERK: protein kinase RNA-like endoplasmic reticulum kinase; p-PERK: phosphorylated PERK; PK1: porcine kidney epithelial cell; STZ: streptozotocin; TM: tunicamycin; TRB3: tribbles-related protein 3; UUO: unilateral ureteral obstruction; XBP1: X-box-binding protein 1.